Alnylam Pharmaceuticals, Inc.
SERPINA1 iRNA COMPOSITIONS AND METHODS OF USE THEREOF
Last updated:
Abstract:
The invention relates to RNAi agents, e.g., double-stranded RNAi agents, targeting the Serpina1 gene, and methods of using such RNAi agents to inhibit expression of Serpina1 and methods of treating subjects having a Serpina1 associated disease, such as a liver disorder.
Status:
Application
Type:
Utility
Filling date:
5 Jan 2021
Issue date:
14 Oct 2021